Grape King Bio Ltd (1707.TW)
TWD 151.0
(0.0%)
TWD 151.0
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 9.81 TWD | -33.04% |
| 2022 | 14.65 TWD | 10.98% |
| 2021 | 13.20 TWD | -5.17% |
| 2020 | 13.92 TWD | -2.45% |
| 2019 | 14.27 TWD | 49.11% |
| 2018 | 9.57 TWD | -4.59% |
| 2017 | 10.03 TWD | 2.14% |
| 2016 | 9.82 TWD | 21.69% |
| 2015 | 8.07 TWD | 11.46% |
| 2014 | 7.24 TWD | 12.77% |
| 2013 | 6.42 TWD | 37.47% |
| 2012 | 4.67 TWD | 28.65% |
| 2011 | 3.63 TWD | 10.67% |
| 2010 | 3.28 TWD | 12.71% |
| 2009 | 2.91 TWD | 130.95% |
| 2008 | 1.26 TWD | -9.35% |
| 2007 | 1.39 TWD | 19.83% |
| 2006 | 1.16 TWD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 2.21 TWD | 27.01% |
| 2024 Q1 | 1.74 TWD | -44.94% |
| 2023 Q2 | 2.28 TWD | -17.69% |
| 2023 Q1 | 2.77 TWD | -41.06% |
| 2023 Q4 | 3.16 TWD | 27.42% |
| 2023 Q3 | 2.48 TWD | 8.77% |
| 2023 FY | - TWD | -33.04% |
| 2022 Q3 | 3.66 TWD | -4.69% |
| 2022 FY | - TWD | 10.98% |
| 2022 Q2 | 3.84 TWD | 57.38% |
| 2022 Q1 | 2.44 TWD | -44.16% |
| 2022 Q4 | 4.70 TWD | 28.42% |
| 2021 Q3 | 2.04 TWD | -7.27% |
| 2021 FY | - TWD | -5.17% |
| 2021 Q1 | 1.60 TWD | -48.22% |
| 2021 Q2 | 2.20 TWD | 37.5% |
| 2021 Q4 | 4.37 TWD | 114.22% |
| 2020 Q1 | 1.93 TWD | -38.73% |
| 2020 Q3 | 2.23 TWD | 6.7% |
| 2020 Q4 | 3.09 TWD | 38.57% |
| 2020 Q2 | 2.09 TWD | 8.29% |
| 2020 FY | - TWD | -2.45% |
| 2019 FY | - TWD | 49.11% |
| 2019 Q3 | 2.24 TWD | -3.03% |
| 2019 Q2 | 2.31 TWD | 19.69% |
| 2019 Q1 | 1.93 TWD | -35.67% |
| 2019 Q4 | 3.15 TWD | 40.62% |
| 2018 Q1 | 1.93 TWD | -41.34% |
| 2018 Q4 | 3.00 TWD | 20.0% |
| 2018 Q3 | 2.50 TWD | 16.82% |
| 2018 FY | - TWD | -4.59% |
| 2018 Q2 | 2.14 TWD | 10.88% |
| 2017 Q3 | 2.45 TWD | 2.94% |
| 2017 Q1 | 1.92 TWD | -34.02% |
| 2017 Q2 | 2.38 TWD | 23.96% |
| 2017 Q4 | 3.29 TWD | 34.29% |
| 2017 FY | - TWD | 2.14% |
| 2016 Q1 | 2.17 TWD | -8.44% |
| 2016 FY | - TWD | 21.69% |
| 2016 Q4 | 2.91 TWD | 15.94% |
| 2016 Q3 | 2.51 TWD | 10.57% |
| 2016 Q2 | 2.27 TWD | 4.61% |
| 2015 Q2 | 1.87 TWD | 2.19% |
| 2015 Q1 | 1.83 TWD | -18.3% |
| 2015 FY | - TWD | 11.46% |
| 2015 Q4 | 2.37 TWD | 17.91% |
| 2015 Q3 | 2.01 TWD | 7.49% |
| 2014 Q3 | 1.89 TWD | 16.67% |
| 2014 Q2 | 1.62 TWD | 8.72% |
| 2014 Q1 | 1.49 TWD | -23.98% |
| 2014 FY | - TWD | 12.77% |
| 2014 Q4 | 2.24 TWD | 18.52% |
| 2013 Q4 | 1.96 TWD | 24.05% |
| 2013 Q2 | 1.54 TWD | 15.79% |
| 2013 FY | - TWD | 37.47% |
| 2013 Q1 | 1.33 TWD | 2.31% |
| 2013 Q3 | 1.58 TWD | 2.6% |
| 2012 Q3 | 1.19 TWD | 11.21% |
| 2012 Q2 | 1.07 TWD | -6.14% |
| 2012 Q1 | 1.14 TWD | 8.57% |
| 2012 FY | - TWD | 28.65% |
| 2012 Q4 | 1.30 TWD | 9.24% |
| 2011 Q2 | 1.04 TWD | 0.97% |
| 2011 Q1 | 1.03 TWD | -11.97% |
| 2011 Q4 | 1.05 TWD | 105.88% |
| 2011 FY | - TWD | 10.67% |
| 2011 Q3 | 0.51 TWD | -50.96% |
| 2010 Q4 | 1.17 TWD | 48.1% |
| 2010 FY | - TWD | 12.71% |
| 2010 Q3 | 0.79 TWD | -3.66% |
| 2010 Q2 | 0.82 TWD | 64.0% |
| 2010 Q1 | 0.50 TWD | 0.0% |
| 2009 FY | - TWD | 130.95% |
| 2008 FY | - TWD | -9.35% |
| 2007 FY | - TWD | 19.83% |
| 2006 FY | - TWD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Standard Chem & Pharm CO., LTD. | 4.67 TWD | -110.064% |
| Maywufa Company Ltd. | 1.27 TWD | -672.441% |
| ScinoPharm Taiwan, Ltd. | 0.36 TWD | -2625.0% |
| Lotus Pharmaceutical Co., Ltd. | 15.72 TWD | 37.595% |
| LIWANLI Innovation Co., Ltd. | 0.06 TWD | -15397.63% |
| YungShin Global Holding Corporation | 3.11 TWD | -215.434% |
| PhytoHealth Corporation | -0.24 TWD | 4187.5% |
| SCI Pharmtech, Inc. | 2.70 TWD | -263.333% |
| Formosa Laboratories, Inc. | 1.05 TWD | -834.286% |
| PharmaEssentia Corporation | -1.93 TWD | 608.29% |
| Bora Pharmaceuticals Co., LTD. | 30.20 TWD | 67.517% |